BioLight Life Sciences Balance Sheet

Financials in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	8.05	9.72	5.28	13.39	33.47	29.99
Short-Term Investments	0.19	-	0.25	1.25	0.25	1.16
Trading Asset Securities	16.17	3.75	3.12	2.99	-	19.96
Cash & Short-Term Investments	24.41	13.47	8.64	17.63	33.71	51.11
Cash Growth	-	55.81%	-50.96%	-47.72%	-34.04%	27.93%
Other Receivables	0.82	-	-	-	0	0.09
Receivables	0.82	-	-	-	0	0.09
Prepaid Expenses	-	0.44	0.07	0.09	0.04	0.01
Other Current Assets	-	0.44	0.34	0.31	0.25	0.25
Total Current Assets	25.22	14.35	9.06	18.02	34	51.46
Property, Plant & Equipment	3.75	4.16	4.27	3.34	3.26	3.16
Long-Term Investments	12.22	13.53	19.37	34.88	25.82	10.06
Goodwill	-	-	-	-	-	0.15
Other Intangible Assets	0.69	0.69	0.69	0.69	0.15	-
Other Long-Term Assets	1.13	1.4	0.07	0.09	0.95	-
Total Assets	43.01	34.12	33.45	57.01	64.17	64.83
Accounts Payable	0.17	0.13	0.24	0.3	0.15	0.58
Accrued Expenses	0.95	1.4	1.51	1.71	1.62	1.52
Current Portion of Leases	0.21	0.53	0.09	0.53	0.44	0.46
Current Unearned Revenue	-	-	0.48	-	-	-
Total Current Liabilities	1.32	2.07	2.32	2.54	2.21	2.56
Long-Term Leases	-	0.07	-	-	-	0.47
Long-Term Unearned Revenue	1.07	1.25	0.84	0.78	0.54	0.56
Long-Term Deferred Tax Liabilities	-	-	-	-	-	1.13
Total Liabilities	2.39	3.38	3.15	3.32	2.75	4.72
Common Stock	296.17	11.65	11.65	11.44	11.4	11.36
Additional Paid-In Capital	-	251.1	250.78	250.46	250.42	248.34
Retained Earnings	-258.44	-249.97	-242.82	-216.8	-208.96	-209.34
Comprehensive Income & Other	-	14.1	10.17	8.07	7.84	8.86
Total Common Equity	37.73	26.88	29.78	53.17	60.7	59.22
Minority Interest	2.9	3.86	0.53	0.52	0.72	0.89
Shareholders' Equity	40.63	30.74	30.3	53.69	61.42	60.11
Total Liabilities & Equity	43.01	34.12	33.45	57.01	64.17	64.83
Total Debt	0.21	0.6	0.09	0.53	0.44	0.93
Net Cash (Debt)	24.2	12.87	8.55	17.1	33.27	50.18
Net Cash Growth	-	50.47%	-49.98%	-48.61%	-33.70%	27.04%
Net Cash Per Share	5.02	2.76	1.84	3.74	7.25	11.05
Filing Date Shares Outstanding	5.26	4.69	4.66	4.64	4.56	4.54
Total Common Shares Outstanding	5.26	4.66	4.66	4.58	4.56	4.54
Working Capital	23.9	12.28	6.74	15.49	31.79	48.9
Book Value Per Share	7.17	5.77	6.39	11.62	13.31	13.04
Tangible Book Value	37.04	26.19	29.09	52.48	60.55	59.07
Tangible Book Value Per Share	7.04	5.62	6.25	11.47	13.28	13.00
Machinery	-	0.56	0.64	0.64	0.54	0.54
Leasehold Improvements	-	-	0.07	0.07	0.07	0.19

Source: S&P Global Market Intelligence. Standard template. Financial Sources.